The phase 1/2 Mobilize trial is evaluating the safety and efficacy of mRNA-4359
Category: Imperial College Healthcare NHS Trust
The institute is one of two UK laboratories wholly funded by the MRC
pharmaceuticals.co.nz
Drugs, medicines and medical news